| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0272989X98018002S09 |
| P698 | PubMed publication ID | 9566468 |
| P2093 | author name string | J Mullahy | |
| A A Stinnett | |||
| P433 | issue | 2 Suppl | |
| P921 | main subject | cost–benefit analysis | Q942582 |
| cost-effectiveness analysis | Q1754768 | ||
| P304 | page(s) | S68-80 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Medical Decision Making | Q6806321 |
| P1476 | title | Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis | |
| P478 | volume | 18 |
| Q92142390 | "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier |
| Q44836122 | A Bayesian model averaging approach for cost-effectiveness analyses |
| Q24261175 | A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control |
| Q33236613 | A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome |
| Q41695109 | A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trial |
| Q51797753 | A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes. |
| Q30654009 | A framework for cost-effectiveness analysis from clinical trial data. |
| Q35647432 | A matched-pair cluster design study protocol to evaluate implementation of the Canadian C-spine rule in hospital emergency departments: Phase III. |
| Q36274875 | A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations |
| Q57801435 | A new approach for sample size calculation in cost-effectiveness studies based on value of information |
| Q21257171 | A phase III randomized three-arm trial of physical therapist delivered pain coping skills training for patients with total knee arthroplasty: the KASTPain protocol |
| Q61446686 | A phase III wait-listed randomised controlled trial of novel targeted inter-professional clinical education intervention to improve cancer patients' reported pain outcomes (The Cancer Pain Assessment (CPAS) Trial): study protocol |
| Q47125009 | A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study |
| Q30985726 | A propensity score approach to estimating the cost-effectiveness of medical therapies from observational data |
| Q33330178 | A randomised clinical trial of subgrouping and targeted treatment for low back pain compared with best current care. The STarT Back Trial Study Protocol. |
| Q42647130 | A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting |
| Q36775820 | A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multi-centre study |
| Q80385167 | A risk-adjusted approach to comparing the return on investment in health care programs |
| Q90583650 | A simple, step-by-step guide to interpreting decision curve analysis |
| Q60303803 | A theoretical foundation for state-transition cohort models in health decision analysis |
| Q64946090 | Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial. |
| Q35026968 | Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies |
| Q77361477 | Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane |
| Q35981535 | Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors |
| Q37240851 | American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. |
| Q36776918 | An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study |
| Q34332212 | An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial |
| Q31075654 | Applying the net-benefit framework for analyzing and presenting cost-effectiveness analysis of a maternal and newborn health intervention |
| Q80603253 | Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models |
| Q37639918 | Associations of participation in community assets with health-related quality of life and healthcare usage: a cross-sectional study of older people in the community. |
| Q77811983 | At what price significance? The effect of price estimates on statistical inference in economic evaluation |
| Q44519601 | Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q47172311 | Bayesian sample size determination for cost-effectiveness studies with censored data |
| Q54217509 | Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis. |
| Q52628777 | Benefit-Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project. |
| Q35159488 | Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space |
| Q38737493 | Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis |
| Q44385779 | Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy |
| Q58753908 | Can occupational therapist-led home environmental assessment prevent falls in older people? A modified cohort randomised controlled trial protocol |
| Q37367296 | Case management at an outpatient unit for severe and enduring eating disorder patients at Stockholm Centre for Eating Disorders- a study protocol |
| Q33347829 | Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial |
| Q33981053 | Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations |
| Q35532586 | Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies |
| Q30506096 | Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis |
| Q40214324 | Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis |
| Q44224300 | Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach. |
| Q36849885 | Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults |
| Q37042131 | Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial |
| Q45344894 | Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis. |
| Q36480975 | Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcers |
| Q37163118 | Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling |
| Q99610380 | Considering the societal perspective in economic evaluations: a systematic review in the case of depression |
| Q49054829 | Continuous time simulation and discretized models for cost-effectiveness analysis |
| Q47185594 | Cost Effectiveness of a School Readiness Intervention for Foster Children |
| Q37223177 | Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. |
| Q37518911 | Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial. |
| Q37268515 | Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care |
| Q33681734 | Cost effectiveness analysis of antenatal HIV screening in United Kingdom |
| Q44270936 | Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophy |
| Q53202985 | Cost effectiveness of an adherence-improving programme in hypertensive patients. |
| Q36929673 | Cost effectiveness of brace, physiotherapy, or both for treatment of tennis elbow |
| Q53150085 | Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis. |
| Q30492745 | Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting |
| Q37099021 | Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET). |
| Q34971542 | Cost effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomised controlled trial |
| Q45891915 | Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective |
| Q45424160 | Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis |
| Q36322941 | Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study |
| Q36225186 | Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics. |
| Q28554655 | Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa |
| Q36994849 | Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program |
| Q41656775 | Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia |
| Q37461370 | Cost-Effectiveness of Nutrition Intervention in Long-Term Care |
| Q37005179 | Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States |
| Q36836401 | Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease |
| Q88495516 | Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes |
| Q37400172 | Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma |
| Q45710710 | Cost-effectiveness acceptability curves revisited |
| Q44596904 | Cost-effectiveness acceptability curves--caveats quantified |
| Q49894684 | Cost-effectiveness analyses of genetic and genomic diagnostic tests |
| Q37325441 | Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial |
| Q27311227 | Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial |
| Q36421418 | Cost-effectiveness analysis of a continuing care intervention for cocaine-dependent adults |
| Q64058874 | Cost-effectiveness analysis of an innovative model of care for chronic wounds patients |
| Q43575717 | Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients |
| Q61797320 | Cost-effectiveness analysis of telephone cognitive-behaviour therapy for adolescents with obsessive-compulsive disorder |
| Q90650990 | Cost-effectiveness analysis of two attachment systems for mandibular overdenture |
| Q36658832 | Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation |
| Q36794924 | Cost-effectiveness and cost-utility of Internet-based computer tailoring for smoking cessation |
| Q60915796 | Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial |
| Q41946984 | Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes |
| Q37576875 | Cost-effectiveness of Early Surgery versus Conservative Treatment with Optional Delayed Meniscectomy for Patients over 45 years with non-obstructive meniscal tears (ESCAPE study): protocol of a randomised controlled trial |
| Q34077749 | Cost-effectiveness of Internet-based self-management compared with usual care in asthma |
| Q49926023 | Cost-effectiveness of a Ceramide-Infused Skin Barrier Versus a Standard Barrier: Findings From a Long-Term Cost-effectiveness Analysis |
| Q87855255 | Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes |
| Q36291124 | Cost-effectiveness of a nurse-led intervention to optimise implementation of guideline-concordant continence care: Study protocol of the COCON study |
| Q34741793 | Cost-effectiveness of a primary care depression intervention |
| Q57982026 | Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis |
| Q95273170 | Cost-effectiveness of adding atezolizumab to first-line chemotherapy in patients with advanced triple-negative breast cancer |
| Q35007549 | Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol |
| Q33855904 | Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania |
| Q35523465 | Cost-effectiveness of caries excavations in different risk groups - a micro-simulation study |
| Q47116826 | Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care |
| Q38851169 | Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation |
| Q34964120 | Cost-effectiveness of genotype testing for primary resistance in Brazil |
| Q33894364 | Cost-effectiveness of guided self-help treatment for recurrent binge eating |
| Q35121405 | Cost-effectiveness of hip protectors in institutional dwelling elderly. |
| Q35337324 | Cost-effectiveness of implementing the chronic care model for diabetes care in a military population. |
| Q24815606 | Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen |
| Q33391049 | Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease |
| Q36939511 | Cost-effectiveness of nutrition interventions in nursing home residents: a pilot intervention |
| Q33821666 | Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom |
| Q44314643 | Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries |
| Q36902923 | Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden |
| Q35402897 | Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom |
| Q35809264 | Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. |
| Q37959923 | Cost-minimisation analysis versus cost-effectiveness analysis, revisited. |
| Q37542450 | Cost-utility analysis of a randomized controlled weight loss trial among lactating overweight/obese women |
| Q89793621 | Cost-utility analysis of learning and coping versus standard education in cardiac rehabilitation: a randomised controlled trial with 3 years of follow-up |
| Q37686922 | Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study |
| Q63248200 | Cost-utility of a disease management program for patients with asthma |
| Q41894111 | Costs and effectiveness of treatment alternatives for proximal caries lesions |
| Q36404741 | Costs and effects in lumbar spinal fusion. A follow-up study in 136 consecutive patients with chronic low back pain |
| Q33568594 | Defining a staged-based process for economic and financial evaluations of mHealth programs |
| Q40243587 | Dengue dynamics and vaccine cost-effectiveness in Brazil. |
| Q36421219 | Determinants of cost-effectiveness in lumbar spinal fusion using the net benefit framework: a 2-year follow-up study among 695 patients |
| Q58057272 | Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues |
| Q35782483 | Development of a web-based tool for the assessment of health and economic outcomes of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). |
| Q43944776 | Development of an economic model to assess the cost effectiveness of asthma management strategies |
| Q40363855 | Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion |
| Q46872604 | Discounting and decision making in the economic evaluation of health-care technologies |
| Q34037515 | Do the potential benefits of metal-on-metal hip resurfacing justify the increased cost and risk of complications? |
| Q33288889 | Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis |
| Q34018902 | Dynamic health policies for controlling the spread of emerging infections: influenza as an example |
| Q37517283 | Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY). |
| Q57152517 | Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive-Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome |
| Q36409170 | Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative |
| Q46082008 | Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease |
| Q37689908 | Economic evaluation of a web-based tailored lifestyle intervention for adults: findings regarding cost-effectiveness and cost-utility from a randomized controlled trial |
| Q36402870 | Economic evaluation of a weight control program with e-mail and telephone counseling among overweight employees: a randomized controlled trial |
| Q47349810 | Economic evaluation of interventions designed to reduce Clostridium difficile infection |
| Q47790469 | Economic evaluation of nebulized magnesium sulphate in acute severe asthma in children |
| Q40397443 | Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme. |
| Q64229841 | Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD) |
| Q36266814 | Economic evaluations: a new avenue of outcome assessment in spinal disorders |
| Q34048585 | Economic issues in the prevention of vertical transmission of HIV. |
| Q52589247 | Effectiveness and cost-effectiveness of fining non-attendance at public hospitals: a randomised controlled trial from Danish outpatient clinics. |
| Q34669493 | Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. |
| Q36769221 | Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis |
| Q36163136 | Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study). |
| Q36996489 | Effects of changing mosquito host searching behaviour on the cost effectiveness of a mass distribution of long-lasting, insecticidal nets: a modelling study. |
| Q89601147 | Effects of participating in community assets on quality of life and costs of care: longitudinal cohort study of older people in England |
| Q36921955 | Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability |
| Q87845790 | Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders |
| Q51913672 | Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach. |
| Q37272487 | Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation |
| Q47653469 | Estimating the opportunity costs of bed-days. |
| Q33649165 | Evaluation of a system of structured, pro-active care for chronic depression in primary care: a randomised controlled trial |
| Q36722716 | Evaluation of the effectiveness and cost-effectiveness of Families for Health V2 for the treatment of childhood obesity: study protocol for a randomized controlled trial |
| Q36359124 | Evidence synthesis, parameter correlation and probabilistic sensitivity analysis |
| Q36848631 | Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients |
| Q51620269 | Exploring uncertainty in cost-effectiveness analysis. |
| Q37355457 | First steps: study protocol for a randomized controlled trial of the effectiveness of the Group Family Nurse Partnership (gFNP) program compared to routine care in improving outcomes for high-risk mothers and their children and preventing abuse |
| Q50295808 | Functional Strength Training and Movement Performance Therapy for Upper Limb Recovery Early Poststroke-Efficacy, Neural Correlates, Predictive Markers, and Cost-Effectiveness: FAST-INdiCATE Trial |
| Q47692291 | Globally optimal trial design for local decision making |
| Q34025543 | Handling uncertainty in cost-effectiveness models |
| Q57131293 | Health Technology Optimization Analysis: Conceptual Approach and Illustrative Application |
| Q36453628 | Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial |
| Q33230071 | Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005. |
| Q38528603 | Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis. |
| Q39614116 | How much are we willing to pay to prevent a fall? Cost-effectiveness of a multifactorial falls prevention program for community-dwelling older adults |
| Q34983557 | How to assess the value of medicines? |
| Q38638180 | How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework |
| Q39568304 | Identifying cost-effective dynamic policies to control epidemics |
| Q40360668 | Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods |
| Q39823216 | Implementing guidelines into clinical practice: what is the value? |
| Q37678671 | Implementing trials of complex interventions in community settings: the USC-Rancho Los Amigos pressure ulcer prevention study (PUPS). |
| Q61856229 | Incorporation of uncertainty in health economic modelling studies |
| Q47111686 | Incremental Net Benefit of Early Intervention for Preschool-Aged Children with Emotional and Behavioral Problems in Foster Care. |
| Q35923024 | Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care |
| Q83390548 | Incremental net benefit and acceptability of alternative health policies: a case study of mass screening for colorectal cancer |
| Q64926725 | Individual results may vary: Inequality-probability bounds for some health-outcome treatment effects. |
| Q33914367 | Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio. |
| Q36635510 | Information created to evade reality (ICER): things we should not look to for answers. |
| Q79756944 | Informing the efficient use of health care and health care research resources - the case of screening for abdominal aortic aneurysm in Sweden |
| Q36617884 | Insights from a conference on implementing comparative effectiveness research through shared decision-making |
| Q37627331 | Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial |
| Q35908186 | Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice? |
| Q36053946 | Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy |
| Q36981420 | It's time to choose the study design!: net benefit analysis of alternative study designs to acquire information for evaluation of health technologies |
| Q33260274 | Joint distribution approaches to simultaneously quantifying benefit and risk |
| Q35789949 | Learning and coping strategies versus standard education in cardiac rehabilitation: a cost-utility analysis alongside a randomised controlled trial. |
| Q51899117 | Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters. |
| Q52933197 | Live long, live well: quantifying the health of heterogeneous populations. |
| Q38543212 | Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. |
| Q27333241 | Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy |
| Q38621230 | Medial compartment knee osteoarthritis: age-stratified cost-effectiveness of total knee arthroplasty, unicompartmental knee arthroplasty, and high tibial osteotomy |
| Q36623869 | Median-Based Incremental Cost-Effectiveness Ratio (ICER) |
| Q50130117 | Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations |
| Q34032524 | Mindful "Vitality in Practice": an intervention to improve the work engagement and energy balance among workers; the development and design of the randomised controlled trial |
| Q48435798 | Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. |
| Q35878722 | Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain |
| Q58696718 | Modelling the cost-effectiveness of pay-for-performance in primary care in the UK |
| Q59297509 | Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA |
| Q30392547 | Moving from efficacy to effectiveness trials in prevention research |
| Q61445256 | Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation |
| Q87133692 | Navigating time and uncertainty in health technology appraisal: would a map help? |
| Q25255836 | Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening |
| Q89474249 | Non-inferiority and cost-effectiveness trial of isolated biceps tenotomy versus tenotomy with rotator cuff repair in patients with stage 2-3 Goutallier fatty degenerative cuff lesions (TenCuRe study): protocol of a multicentre randomised controlled |
| Q51839068 | Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. |
| Q36834267 | OFT, VBP: QED? |
| Q24806506 | On the probability of cost-effectiveness using data from randomized clinical trials |
| Q30833150 | One Health approach to cost-effective rabies control in India |
| Q77482295 | Opportunity costs and uncertainty in the economic evaluation of health care interventions |
| Q38093054 | Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharing |
| Q35905223 | Optimal sequence of tests for the mediastinal staging of non-small cell lung cancer. |
| Q38730575 | Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART. |
| Q87035432 | Output correlations in probabilistic models with multiple alternatives |
| Q33692552 | Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. |
| Q39353931 | Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile. |
| Q51988042 | Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. |
| Q46841298 | Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness |
| Q53251677 | Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. |
| Q51558387 | Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies. |
| Q80787019 | Presenting results of probabilistic sensitivity analysis: the incremental benefit curve |
| Q47103345 | Preventing enduring behavioural problems in young children through early psychological intervention (Healthy Start, Happy Start): study protocol for a randomized controlled trial |
| Q37446922 | Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe |
| Q53588564 | Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/Illa antagonists in non-ST elevation acute coronary syndrome. |
| Q90550392 | Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models |
| Q24121283 | Protocol Evaluating the effectiveness of a school-based group programme for parents of children at risk of ADHD: the 'PArents, Teachers and CHildren WORKing Together (PATCHWORK)' cluster RCT protocol |
| Q89560831 | Protocol for a longitudinal study of melatonin therapy and cost effectiveness analysis in stimulant-treated children with ADHD and insomnia: An N-of-1 trial |
| Q33973056 | Protocol for an economic evaluation alongside the University Health Network Whiplash Intervention Trial: cost-effectiveness of education and activation, a rehabilitation program, and the legislated standard of care for acute whiplash injury in Ontar |
| Q94028111 | Quantitative Methods for Valuing Comparative Effectiveness Information |
| Q34632774 | RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care |
| Q28657925 | Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT) |
| Q83073075 | Real economics needs to reflect real decisions: a response to Johnson |
| Q34494172 | Repeated mass distributions and continuous distribution of long-lasting insecticidal nets: modelling sustainability of health benefits from mosquito nets, depending on case management |
| Q47573256 | Representing uncertainty: the role of cost-effectiveness acceptability curves |
| Q64133139 | Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach |
| Q47391808 | Sample size and power for cost-effectiveness analysis (part 1). |
| Q37944317 | Sample size determination for cost-effectiveness trials |
| Q61853098 | Sensitivity of treatment recommendations to bias in network meta-analysis |
| Q54996386 | Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial. |
| Q31096653 | Shortened peginterferon and ribavirin treatment for chronic hepatitis C. |
| Q47667703 | Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health system. |
| Q50499409 | Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. |
| Q52065721 | Statistical cost-effectiveness analysis of two treatments based on net health benefits. |
| Q52043708 | Statistical determination of cost-effectiveness frontier based on net health benefits. |
| Q58476514 | Stochastic league tables: an application to diabetes interventions in the Netherlands. |
| Q74245483 | Stochastic league tables: communicating cost-effectiveness results to decision-makers |
| Q58057221 | Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria |
| Q43099575 | Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. |
| Q37516685 | Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people w |
| Q90060026 | Subcategorizing the Expected Value of Perfect Implementation to Identify When and Where to Invest in Implementation Initiatives |
| Q81923879 | Subgroups and heterogeneity in cost-effectiveness analysis |
| Q34398384 | Supporting teachers and children in schools: the effectiveness and cost-effectiveness of the Incredible Years teacher classroom management programme in primary school children: a cluster randomised controlled trial, with parallel economic and proces |
| Q64117484 | Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries |
| Q37679483 | That's what friends are for: adolescent peer social status, health-related quality of life and healthcare costs |
| Q35336802 | The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug |
| Q40397786 | The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System? |
| Q30611133 | The REFORM study protocol: a cohort randomised controlled trial of a multifaceted podiatry intervention for the prevention of falls in older people |
| Q33164400 | The STRIDE (Strategies to Increase confidence, InDependence and Energy) study: cognitive behavioural therapy-based intervention to reduce fear of falling in older fallers living in the community - study protocol for a randomised controlled trial |
| Q33939428 | The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol |
| Q34195493 | The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis |
| Q55359786 | The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measures. |
| Q36886256 | The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis |
| Q30775597 | The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation. |
| Q47557070 | The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. |
| Q34107893 | The cost-effectiveness of screening for colorectal cancer |
| Q35147398 | The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. |
| Q34361410 | The development of the Be Active & Relax "Vitality in Practice" (VIP) project and design of an RCT to reduce the need for recovery in office employees |
| Q55217201 | The economic case for precision medicine. |
| Q35622994 | The impact of comparative effectiveness research on health and health care spending |
| Q57395637 | The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study |
| Q73122940 | The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies |
| Q40496852 | The measurement of contingent valuation for health economics |
| Q24805121 | The probability of cost-effectiveness |
| Q51009835 | The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. |
| Q36783257 | The value of innovation under value-based pricing |
| Q92603811 | Threshold Analysis as an Alternative to GRADE for Assessing Confidence in Guideline Recommendations Based on Network Meta-analyses |
| Q46103096 | Training Nonnursing Staff to Assist with Nutritional Care Delivery in Nursing Homes: A Cost-Effectiveness Analysis |
| Q34854149 | Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up |
| Q33758436 | Understanding proximal-distal economic projections of the benefits of childhood preventive interventions |
| Q91071246 | Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis |
| Q61853095 | Use of a random effects meta-analysis in the design and analysis of a new clinical trial |
| Q47193269 | Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal |
| Q47175031 | Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration |
| Q64998984 | Using a Health Economic Framework to Prioritize Quality Indicators: An Example With Smoking Cessation in Chronic Obstructive Pulmonary Disease. |
| Q31037061 | Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation |
| Q33208109 | Using covariates to reduce uncertainty in the economic evaluation of clinical trial data |
| Q80189535 | Using discrete choice experiments within a cost-benefit analysis framework: some considerations |
| Q41591206 | Using the Payoff Time in Decision-Analytic Models: A Case Study for Using Statins in Primary Prevention |
| Q31043509 | Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope |
| Q34144767 | VIP in construction: systematic development and evaluation of a multifaceted health programme aiming to improve physical activity levels and dietary patterns among construction workers |
| Q64963591 | Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions. |
| Q96348245 | Which valued-based price when patients are heterogeneous? |
| Q33645702 | Willingness to pay as a measure of health benefits |
Search more.